Troponin T Fragmentation in the Assessment of Myocardial Injury Study

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Troponin T (TnT) is a part of the troponin protein complex that principally exists in cardiac and skeletal muscle cells and is widely used as diagnostic biomarker for myocardial injury and, thus, myocardial infarction (MI). Elevated TnT levels can, however, be observed in the presence of other clinical conditions such as heart failure, sepsis and kidney failure and the contemporary high-sensitivity TnT test may yield false positive results when performing diagnostics for suspected MI in these patients. Recent data have demonstrated that in the presence of MI, TnT gradually undergoes fragmentation into smaller fragments. It has been suggested that in the presence of e.g. chronic kidney disease or physical exercise the released TnT is predominantly in the form of smaller fragments. However, the clinical significance of TnT fragmentation is unknown and, thus, we sought to investigate the prevalence of fragmentation of TnT in different patient cohorts.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Troponin T fragmentation sample collected from a recruited patient.

Locations
Other Locations
Finland
Turku University Hospital, Heart Center
RECRUITING
Turku
Switzerland
University Hospital Zurich
ENROLLING_BY_INVITATION
Zurich
Contact Information
Primary
Juhani K Airaksinen, MD, PhD
juhani.airaksinen@tyks.fi
+358 2 3131005
Time Frame
Start Date: 2020-04-02
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 1500
Treatments
Myocardial infarction
Recruited patients with STEMI or NSTEMI and elevated Troponin T
Myocardial injury
Recruited patients with myocardial injury based on elevated Troponin T and associated with renal failure, severe infection, strenouos exercise, atrial fibrillation, myocarditis, takotsubo cardiomyopathy or other similar conditions
Sponsors
Leads: University of Turku

This content was sourced from clinicaltrials.gov